Potentiating new Neurological pain drugs from cannabis (CBD/THC)
Sean Hall, MD
MedLab Clinical Limited
In this presentation, Dr. Hall discusses active research identifying new neurological drugs based on cannabis, specifically CBD/THC derived products for use in pain management.
Neurology is a complex area, potentially requiring a combination of surgical and non-surgical intervention. Regardless of the intervention plan, Neurology is hindered with a number of co-morbidities that can diminish patient outcomes, one in particular is pain. Pain management requires a number of pharmaceutical agents principally from the opioid class of drugs, potentiating heightened secondary organ toxicity profiles. Further it is accepted that some 33% + of patients undergoing chemotherapy will state that their pain is under-managed. Cannabinoids potentiate new treatments in pain management and posit opioid reduction.
Handouts of Slides: